Skip to content

Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Trapezius MFTrPs

Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Upper Trapezius Myofascial Trigger Points- a Randomized Intervention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01710735
Enrollment
80
Registered
2012-10-19
Start date
2011-04-30
Completion date
2012-09-30
Last updated
2012-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome

Keywords

TP, Myofascial pain

Brief summary

In relation to Myofascial Triggerpoints (MFTrPs) of the upper Trapezius, this study will explore muscle contractility characteristics, the occurrence of post-intervention muscle soreness and the effect of dry needling on muscle contractile characteristics and clinical outcomes.

Interventions

PROCEDUREDry needling

Insertion of acupuncture needle into a myofascial trigger point.

Sponsors

Lundbeck Foundation
CollaboratorOTHER
Dansk Kiropraktor Fond
CollaboratorUNKNOWN
IMK Almene Fond
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 46 Years
Healthy volunteers
Yes

Inclusion criteria

* A clinically relevant MFTrP of the upper Trapezius musculature * Self-reported pain of ≥3 on an eleven-point numerical pain rating scale (NRS-101). * BMI less than 31

Exclusion criteria

* a history of chronic, systemic pathology (e.g. hemophilia) * pre-existing neck/shoulder pathology/surgical procedures, * clinical depression * health-related legal action * pregnant * anti-inflammatory and/or chronic pain medication * had received dry needling for a shoulder/neck disorder within 6 months prior to the study (to raise the level of patient naiveté) suffered from needle phobia

Design outcomes

Primary

MeasureTime frameDescription
muscle contractility30 minutesMeasurements of maximal isometric muscle force (Fmax), and rate of force development (RDF)

Secondary

MeasureTime frameDescription
pressure-pain threshold60 secondsAlgometer measurement of pressure-pain perception
NRS-10160 secondsSelf-reported pain

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026